Committee for Orphan Medicinal Products (COMP): 5-6 January 2010
EventHumanRare diseases
On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.
Date
Location
The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases. It does not currently publish the minutes or agendas of its meetings. It does publish a meeting report after each meeting.